Home » Topics » BioWorld Science

BioWorld Science
RSS

Atux Iskay presents preclinical data on PP2A activator ATUX-792 in IPF

May 30, 2022

TrxR inhibitor Au-24 shows promise in vivo and in vitro for treating hepatocellular carcinoma

May 30, 2022

Morc2 S87L mutation in mice mimics human Charcot-Marie-Tooth disease

May 30, 2022

Broadenbio synthesizes new MAP4K1 inhibitors

May 30, 2022

Betta Pharmaceuticals identifies new IDH inhibitors

May 30, 2022

Tyligand Bioscience divulges GTPase KRAS mutant inhibitors

May 30, 2022

Sichuan Haisco Pharmaceutical patents ENPP2 inhibitors

May 30, 2022

Shanghai Yao Biotech discloses new TRK inhibitors

May 30, 2022

MAb-loaded extracellular vesicles show potential as cancer therapeutics

May 30, 2022

NLRP3 inflammasome inhibitor INF-176 for the treatment of Alzheimer's disease

May 30, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...